Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2007 Jul;151(6):725-36.
doi: 10.1038/sj.bjp.0707263. Epub 2007 Apr 30.

Chemokines and their receptors as potential targets for the treatment of asthma

Affiliations
Review

Chemokines and their receptors as potential targets for the treatment of asthma

C Palmqvist et al. Br J Pharmacol. 2007 Jul.

Abstract

Asthma is a chronic and sometimes fatal disease, which affects people of all ages throughout the world. Important hallmarks of asthma are airway inflammation and remodelling, with associated bronchial hyperresponsiveness and variable airflow obstruction. These features are orchestrated by cells of both the innate (eosinophils, neutrophils and mast cells) and the adaptive (T(H)2 T cells) immune system, in concert with structural airway cells. Chemokines are important for the recruitment of both immune and structural cells to the lung, and also for their microlocalisation within the lung tissue. Specific blockade of the responses elicited by chemokines and chemokine receptors responsible for the pathological migration of airway cells could therefore be of great therapeutic interest for the treatment of asthma.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Bronchial biopsy specimen from a patient with asthma showing mast cell infiltration of airway smooth muscle.
Figure 2
Figure 2
Chemokines and chemokine receptors with potential as therapeutic targets for the treatment of asthma.

Similar articles

Cited by

References

    1. Akbari O, Faul JL, Hoyte EG, Berry GJ, Wahlstrom J, Kronenberg M, et al. CD4+ invariant T-cell-receptor+natural killer T cells in bronchial asthma. N Engl J Med. 2006;354:1117–1129. - PubMed
    1. Barnes PJ, Adcock IM. How do corticosteroids work in asthma. Ann Intern Med. 2003;139 5 Part 1:359–370. - PubMed
    1. Bazan JF, Bacon KB, Hardiman G, Wang W, Soo K, Rossi D, et al. A new class of membrane-bound chemokine with a CX3C motif. Nature: 1997;385:640. - PubMed
    1. Becker EL. Elements of the history of our present concepts of anaphylaxis, hay fever and asthma. Clin Exp Allergy. 1999;29:875. - PubMed
    1. Benayoun L, Druilhe A, Dombret MC, Aubier M, Pretolani M. Airway structural alterations selectively associated with severe asthma. Am J Respir Crit Care Med. 2003;167:1360–1368. - PubMed